PAD Profile : Imipramine hydrochloride - Pain (Neuropathic)

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Imipramine hydrochloride - Pain (Neuropathic)

PAD Profile : Imipramine hydrochloride - Pain (Neuropathic)

Keywords :

Tricyclic antidepressants, TCAs, tricyclics, PHN, post herpetic neuralgia, postherpetic neuralgia, diabetic neuropathy, neuropathic pain

Traffic Light Status

Status 1 of 1.

Status :

Non Formulary

Formulations :

Not Specified

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

Comments :

No comments returned.

Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Overactive bladder (adults)

Additional Documents

Type

Document

Review Date

Guidelines (Local)

Neuropathic Pain Guidelines for Primary Care - Oct 20

01 October 2023

Guidelines (National)

NICE Clinical guideline [CG173] : Neuropathic pain in adults: pharmacological management in non-specialist settings

Committee Recommendations

Date

Committee Name

Narrative

07 October 2020

Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Imipramine is no longer included in local guidelines for use in neuropathic pain.

Imipramine should not be initiated in any new patients for this indication.

Amitriptyline is the only tricyclic recommended by NICE. It recommends a switch to another class of drug if amitriptyline is not tolerated or contra-indicated.

See guidelines below.

Associated BNF Codes

04. Central Nervous System

04.07.03. Neuropathic pain